Opportunity Information: Apply for PA 08 064
Apply for PA 08 064
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Decision Making in Cancer Single Event Decisions (R21)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.361 Nursing Research 93.399 Cancer Control.
- This funding opportunity was created on Dec 5, 2008 and posted on Jan 10, 2008.
- Applicants must submit their applications by Jan 7, 2011. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification) County governments Native American tribal organizations (other than Federally recognized tribal governments) Public and State controlled institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments Special district governments State governments Native American tribal governments (Federally recognized) Small businesses Independent school districts For profit organizations other than small businesses Public housing authorities/Indian housing authorities Private institutions of higher education.
- Foreign institutions are eligible to apply. Eligible agencies of the Federal Government can apply. Faith based or community based organizations can apply.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Decision Making in Cancer Single Event Decisions (R21) opportunity (Funding Opportunity Number PA-08-064) is a National Institutes of Health program led through the National Cancer Institute that supports exploratory research aimed at improving how people make cancer-related health decisions. The core goal is to strengthen scientific understanding of the human judgment and decision-making processes that shape real-world choices, so that patients and health care providers can make decisions that are better informed and ultimately more satisfying. The focus is specifically on "single event" decisions, meaning a discrete choice made at a particular point in time, rather than long-running patterns of behavior or repeated decisions across many occasions. These one-time or time-bounded decisions can occur anywhere along the cancer continuum, including prevention (for example, deciding about vaccination or risk-reducing strategies), detection and screening (whether and when to be screened, whether to pursue follow-up testing), treatment (choosing among therapy options, participating in trials), survivorship (managing late effects, surveillance planning), and end-of-life care (advance care planning, palliative and hospice decisions).
A central theme of the announcement is encouraging collaboration between two communities that do not always work closely together: investigators who study basic mechanisms of judgment and decision making (such as how people interpret risk, deal with uncertainty, use heuristics, experience regret, or weigh short-term versus long-term outcomes) and researchers working in cancer control and related clinical or population settings. The intent is to bring decision science approaches into practical cancer-related contexts, producing insights that can explain why certain decisions are difficult, how information is processed under stress or time pressure, and what kinds of decision supports or communication strategies might help. Projects can examine decision making at the level of individual patients, clinicians, or other providers, depending on where the single event decision occurs and who is making it.
This funding uses the NIH Exploratory/Developmental Research Grant mechanism (R21), which is typically designed for early-stage, innovative, or high-potential ideas that may still be developing preliminary evidence. The FOA is described as running in parallel with a companion announcement of identical scientific scope that uses the R01 mechanism (PA-08-063), which generally supports larger, more mature research programs. Awards under PA-08-064 depend on the availability of funds and on the number of high-quality applications received; the notice does not promise a fixed number of awards.
From an administrative and eligibility standpoint, PA-08-064 is a discretionary grant opportunity in the NIH health area (CFDA listings include 93.361 Nursing Research and 93.399 Cancer Control). It does not require cost sharing or matching. Eligibility is broad and includes many types of applicants such as public and private institutions of higher education, nonprofit organizations (both 501(c)(3) and non-501(c)(3)), state and local governments (including counties, cities or townships, special districts, and independent school districts), tribal governments and tribal organizations, public housing authorities/Indian housing authorities, small businesses, and certain for-profit organizations. The announcement also notes that foreign institutions are eligible to apply, eligible federal agencies may apply, and faith-based or community-based organizations can apply as well, subject to the detailed eligibility language in the full FOA.
Key dates in the record show the opportunity was posted January 10, 2008, with a closing date of January 7, 2011, and an archive date of February 7, 2011, indicating it is no longer active as a current solicitation. The full announcement was hosted on the NIH Grants Guide site at http://grants.nih.gov/grants/guide/pa-files/PA-08-064.html, and the NIH Office of Extramural Research webmaster contact was provided for access or linking issues (FBOWebmaster@OD.NIH.GOV).
Frequently Asked Questions (FAQs)
What is the "Decision Making in Cancer Single Event Decisions (R21)" grant opportunity?
It is a National Institutes of Health (NIH) funding opportunity led through the National Cancer Institute (NCI) that supports exploratory research on how people make cancer-related health decisions. The goal is to improve scientific understanding of judgment and decision-making processes so that cancer-related choices are better informed and more satisfying for patients and health care providers.
What is the Funding Opportunity Number for this announcement?
The Funding Opportunity Number is PA-08-064.
Which NIH mechanism does this opportunity use?
This opportunity uses the NIH Exploratory/Developmental Research Grant mechanism, known as an R21.
What kinds of research does an R21 typically support in this context?
The R21 mechanism is typically designed for exploratory, developmental, or early-stage ideas that are innovative or high-potential, including projects where preliminary evidence may still be emerging.
What does "single event" decision mean in this announcement?
"Single event" decisions are discrete choices made at a particular point in time (or within a time-bounded window), rather than ongoing patterns of behavior or repeated decisions across many occasions.
What types of cancer-related decisions are in scope?
The announcement highlights single event decisions that can occur across the cancer continuum, including prevention, detection and screening, treatment, survivorship, and end-of-life care.
Can you give examples of prevention decisions that fit this FOA?
Yes. The FOA gives examples such as deciding about vaccination or choosing risk-reducing strategies.
What detection or screening decisions are relevant?
Examples include whether to be screened, when to be screened, and whether to pursue follow-up testing.
What treatment decisions are relevant?
Examples include choosing among therapy options and deciding whether to participate in clinical trials.
What survivorship decisions are relevant?
Examples include managing late effects and planning surveillance.
What end-of-life decisions are relevant?
Examples include advance care planning and decisions related to palliative care and hospice.
Who is the target decision-maker in studies supported by this FOA?
Projects may examine decision making by individual patients, clinicians, or other providers, depending on where the single event decision occurs and who is making it.
What is the main scientific theme or emphasis of the announcement?
A central theme is encouraging collaboration between two groups: (1) investigators studying basic mechanisms of judgment and decision making and (2) researchers working in cancer control and related clinical or population settings. The intent is to bring decision science approaches into practical cancer-related contexts.
What kinds of decision science topics does the FOA mention?
The FOA gives examples such as how people interpret risk, deal with uncertainty, use heuristics, experience regret, and weigh short-term versus long-term outcomes.
What practical questions or outcomes is the FOA trying to address?
It aims to generate insights into why certain cancer-related decisions are difficult, how information is processed under stress or time pressure, and what kinds of decision supports or communication strategies might help.
Is there a companion opportunity with the same scientific scope?
Yes. The FOA states it runs in parallel with a companion announcement of identical scientific scope that uses the R01 mechanism: PA-08-063.
How does the companion R01 relate to this R21?
Based on the description provided, the R01 (PA-08-063) is generally intended for larger, more mature research programs, while this R21 (PA-08-064) supports more exploratory or developmental projects.
Does the announcement guarantee a fixed number of awards?
No. The FOA indicates that awards depend on the availability of funds and the number of high-quality applications received, and it does not promise a fixed number of awards.
Is cost sharing or matching required?
No. The opportunity states that it does not require cost sharing or matching.
What broad types of organizations are eligible to apply?
Eligibility is described as broad and includes public and private institutions of higher education, nonprofit organizations (501(c)(3) and non-501(c)(3)), state and local governments (including counties, cities or townships, special districts, and independent school districts), tribal governments and tribal organizations, public housing authorities/Indian housing authorities, small businesses, and certain for-profit organizations.
Are foreign institutions eligible to apply?
Yes. The announcement notes that foreign institutions are eligible to apply.
Are federal agencies eligible to apply?
Yes. The announcement notes that eligible federal agencies may apply.
Can faith-based or community-based organizations apply?
Yes. The announcement notes that faith-based or community-based organizations can apply as well, subject to the detailed eligibility language in the full FOA.
What is the CFDA/assistance listing information referenced for this opportunity?
The record references CFDA listings including 93.361 (Nursing Research) and 93.399 (Cancer Control).
When was this opportunity posted?
The record indicates the opportunity was posted on January 10, 2008.
What were the closing and archive dates?
The record shows a closing date of January 7, 2011, and an archive date of February 7, 2011.
Is PA-08-064 currently active?
No. Based on the listed closing and archive dates, it is no longer active as a current solicitation.
Where can the full FOA text be found?
The full announcement was hosted on the NIH Grants Guide site at: http://grants.nih.gov/grants/guide/pa-files/PA-08-064.html
Who is the technical contact for access or linking issues to the FOA?
The NIH Office of Extramural Research webmaster contact provided for access or linking issues is FBOWebmaster@OD.NIH.GOV.
Which NIH institute leads this program?
The opportunity is described as an NIH program led through the National Cancer Institute (NCI).
Is the focus limited to patients only?
No. The description explicitly includes decision making by patients and by health care providers (including clinicians or other providers), depending on the decision context.
Does the FOA focus on repeated behaviors or long-running patterns?
No. The stated focus is on discrete, single event decisions rather than long-running patterns of behavior or repeated decisions across many occasions.
Browse more opportunities from the same category: Education Health
Next opportunity: The Science and Ecology of Early Development (SEED) R03
Previous opportunity: Decision Making in Cancer Single Event Decisions (R01)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PA 08 064
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PA 08 064) also looked into and applied for these:
| Funding Opportunity |
|---|
| Research on the Economics of Diet, Activity and Energy Balance (R21) Apply for PA 08 077 Funding Number: PA 08 077 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| NLM Express Research Grants in Biomedical Informatics (R01) Apply for PAR 08 080 Funding Number: PAR 08 080 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| The Effect of Racial and Ethnic Discrimination/Bias on Health Care Delivery (R21) Apply for PA 08 084 Funding Number: PA 08 084 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| The Effect of Racial and Ethnic Discrimination/Bias on Health Care Delivery (R03) Apply for PA 08 085 Funding Number: PA 08 085 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Functional Links between the Immune System, Brain Function and Behavior (R01) Apply for PA 08 097 Funding Number: PA 08 097 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Functional Links between the Immune System, Brain Function and Behavior (R21) Apply for PA 08 098 Funding Number: PA 08 098 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Cancer Education Grants Program (R25) Apply for PAR 08 120 Funding Number: PAR 08 120 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Symptom Interactions in Cancer and Immune Disorders (R01) Apply for PA 08 121 Funding Number: PA 08 121 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Symptom Interactions in Cancer and Immune Disorders (R21) Apply for PA 08 122 Funding Number: PA 08 122 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Epidemiology Of Drug Abuse (R01) Apply for PA 08 124 Funding Number: PA 08 124 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Epidemiology Of Drug Abuse (R21) Apply for PA 08 125 Funding Number: PA 08 125 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Epidemiology Of Drug Abuse (R03) Apply for PA 08 126 Funding Number: PA 08 126 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Enhancing Tumoricidal Activity of Natural Killer (NK) Cells by Dietary Components for Cancer Prevention (R01) Apply for PA 08 131 Funding Number: PA 08 131 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Enhancing Tumoricidal Activity of Natural Killer (NK) Cells by Dietary Components for Cancer Prevention (R21) Apply for PA 08 132 Funding Number: PA 08 132 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Prescription Drug Misuse (R01) Apply for PA 08 127 Funding Number: PA 08 127 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Prescription Drug Misuse (R21) Apply for PA 08 128 Funding Number: PA 08 128 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Prescription Drug Misuse (R03) Apply for PA 08 129 Funding Number: PA 08 129 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Exploratory/Developmental Grant for Complementary and Alternative Medicine (CAM) Studies of Humans (R21) Apply for PAR 08 135 Funding Number: PAR 08 135 Agency: National Institutes of Health Category: Education Health Funding Amount: $250,000 |
| Correlative Studies with Specimens from Multi Site Trials (R21) Apply for PA 08 133 Funding Number: PA 08 133 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Correlative Studies with Specimens from Multi Site Trials (R01) Apply for PA 08 134 Funding Number: PA 08 134 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants

Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PA 08 064", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
